Background There are multiple reviews on cardiovascular aspects of COVID-19 disease on
cardiovascular system in different population but there is lack of evidence about …

SARS-CoV-2 vaccine–associated myocarditis/myocardial injury should be evaluated in the
contexts of COVID-19 infection, other types of viral myocarditis, and other vaccine …

COVID-19 vaccines have been widely used to reduce the incidence and disease severity of
COVID-19. Questions have lately been raised about the possibility of an association …

Myocarditis and pericarditis are rare adverse reactions, more commonly seen in young
males after receiving the second dose of an mRNA vaccine. However, the benefits of …

There have been massive studies to develop an effective vaccine against SARS-CoV-2
which fortunately led to manage the recent pandemic, COVID-19. According to the quite …

According to recent epidemiological analysis, the percentage of world population infected
with COVID-19 by end of December 2020 is approximately 12.56% 1. COVID induced acute …

Following mass vaccinations for the control of the COVID-19 epidemic, a spectrum of cardiac
and neurological disorders was reported among vaccinated individuals. This study …

Vaccination is significant to control, mitigate, and recover from the destructive effects of
coronavirus disease 2019 (COVID-19). The incidence of myocarditis following COVID-19 …

The rapid development and deployment of mRNA and non-mRNA COVID-19 vaccines have
played a pivotal role in mitigating the global pandemic. Despite their success in reducing …

This is a case study of a 55-year-old patient who died four months after receiving the mRNA-
vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 as a second dose, following an …